Rume Medical Group, INC.

Rume Medical Group, INC. was paid $66K by Medicaid between Oct 2022 and Jan 2023, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 77% of everything it billed.

33Billing provider infoRUME MEDICAL GROUP, INC.
COSTA MESA, CA 92626

33aNPI1528776564assigned 11/08/2022

33bProvider typeClinical Medical Laboratory

28Total paid$66K

24GClaims1,493

24DCodes billed4

24AFirst – last monthOct 2022 – Jan 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#350 of 561

Median peer was paid$222K

This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	1,349	$58K
2023	144	$7K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	77%	721	502	$50K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	21%	678	474	$14K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	1.6%	14	12	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	80	52	$375.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialABINANTE, MATTHEW (CEO)

Same official

Other billing entities under ABINANTE, MATTHEW

Full network →

Provider	Location	Paid
Elevated Health INC	Huntington Beach, CA	$320K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.